PPARγ activation in N2A cells and neurodegenerative disease
碩士 === 慈濟大學 === 生理暨解剖醫學碩士班 === 99 === It has been demonstrated that PPARγ agonists reduce neuronal cell loss in in vitro models of neurotoxicity and in in vivo models of Alzheimer's Disease, Parkinson’s disease and amyotrophic lateral sclerosis. In this study, we treat rosiglitazone three days...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2011
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/76431545622471797122 |